Abstract:Objective To study the mechanisms of cefditoren-resistance in the clinical strains of Streptococcus pneumoniae. Methods Thirt -seven strains of S. pneumoniae with cefditoren MICs of ≥1 mg/L were isolated from community-acquired respiratory tract infections in 10 teaching hospitals from January 2009 to January 2010. Six strains of S. pneumoniae with cefditoren MICs of ≤0.5 mg/L were collected as control group. Broth microdilution method was used to determine the MICs of penicillin, amoxicillin-clavulanic acid, cefuroxime, cefaclor, cefditoren, ceftriaxone, azithromycin, clarithromycin, levofloxacin, moxifloxacin and vancomycin. Multiplex-PCR was used to determine the serotypes of all the test isolates. PCR was used to amplify the genes of pbp2b, pbpla, pbp2x and murM in 43 clinical isolates. PCR products were digested by restriction enzyme to analyze the DNA fingerprints. One to five PCR products exhibiting the same DNA fingerprint pattern were sequenced. Amino acid sequences were then compared to the sequence of S. pneumoniae strain R6 to analyze the mutations in the conserved motifs of PBP genes, especially for SXXK box, SXN box and KT(S)G box. Results Isolates were divided into three groups according to the susceptibility profile: CI group included 3 strains which were susceptible to penicillin and with cefditoren WIC of≤0.5 mg/L; C2 group included 3 strains which were intermediate to penicillin and with cefditoren WIC of≤0.5 mg/L; R group included 37 strains which were intermediate to penicillin and with cefditoren MIC of 1-4 mg/L. Isolates from group R were all susceptible to levofloxacin, moxifloxacin and vancomycin, and resistant to cefuroxime, cefaclor, azithromycin and clarithromycin. Only 8.2% and 5.4% of the isolates were susceptible to amoxicillin-clavulanic acid and ceftriaxone, separately. The serotyping results indicated that 37 isolates of group R included 35 isolates with type 19F, 1 with type 14 and 1 with type 19A The conserved motifs of PBPs in CI group had no mutations when compared with R6. However, the conserved motifs of PBPs in C2 group isolates had following common mutations: Thr445→Ala in PBP2B, Thr371→Ser/Ala and Pro432→Thr in PBPlA, Thr338→Ala and Leu546→Val in PBP2X. For group R, additional mutations of Ala618→Gly in PBP2B, Met339→Phe and Tyr595→Phein PBP2X were found in addition to the mutations in group C2. Conclusions The mutations of PBP2B, PBPlA and PBP2X have close relationship to cefditoren-resistance in S. pneumoniae. Ala618→Gly in PBP2B, Met339→Phe and Tyr595→Phe in PBP2X may be highly related to the increasing cefditoren MICs.

In vitro activity of cefditoren and other comparators against Streptococcus pneumoniae, Haemophilus influenzae, and Moraxella catarrhalis causing community-acquired respiratory tract infections in China.

A multicenter study on the in vitro antibacterial activity of cefoselis against common clinical bacteria

Causative Agent Distribution and Antibiotic Therapy Assessment among Adult Patients with Community Acquired Pneumonia in Chinese Urban Population.

Antimicrobial Susceptibility of Streptococcus Pneumoniae, Haemophilus Influenzae and Moraxella Catarrhalis Isolated from Community-Acquired Respiratory Tract Infections in China: Results from the CARTIPS Antimicrobial Surveillance Program.

Antimicrobial activity of ceftobiprole and comparator agents when tested against gram-positive and -negative organisms collected across China (2016–2018)

In Vitro Activities of Ceftaroline/Avibactam, Ceftazidime/Avibactam, and Other Comparators Against Pathogens from Various Complicated Infections in China.

In vitro activity of cefcapene

In vitro activities of cefoselis compared to β-lactams and other antibacterial agents aganst gram-positive and gram-negative clinical isolates

A Comparison of in Vitro Activity Between Cefprozil and Other Antimicrobial Agents Against Pathogens in Community-Acquired Respiratory Tract Infections

In Vitro Activity and Clinical Efficacy of Macrolides, Cefoperazone-Sulbactam and Piperacillin/piperacillin-Tazobactam Against Bordetella Pertussis and the Clinical Manifestations in Pertussis Patients Due to These Isolates: A Single-Centre Study in Zhejiang Province, China.

Comparative Activities of Sitafloxacin Against Recent Clinical Isolates in Hospitals Across China

In vitro activity of cefminox and comparators against Escherichia coli, Klebsiella pneumoniae and Bacteroides species

In Vitro Activity of Lefamulin Against the Common Respiratory Pathogens Isolated from Mainland China During 2017–2019

Susceptibility of Cefiderocol and Other Antibiotics Against Carbapenem-Resistant, Gram-negative Bacteria

In Vitro Antibacterial Activities of Cefiderocol Against Gram-negative Clinical Strains Isolated from China in 2020.

In vitro activity of cefazolin pentahydrate

In vitro activity of cefiderocol and comparator antibiotics against multidrug-resistant non-fermenting Gram-negative bacilli

In Vitro Antibacterial Activity of Ceftobiprole and Comparator Compounds against Nation-Wide Bloodstream Isolates and Different Sequence Types of MRSA

Antibiotic resistance of common pathogens isolated from community-acquired respiratory infection in China during 2004-2005

Mechanisms of cefditoren-resistance in the strains of Streptococcus pneumoniae isolated from community-acquired respiratory tract infections

In vitro activity of Cefiderocol against Gram-negative pathogens isolated from people with cystic fibrosis and bronchiectasis.